Influence of sleep duration and quality on depression symptoms among nurses during the Omicron outbreak: a cross-sectional survey.

Publication date: Feb 03, 2025

Nurses who work during the global pandemic are known to experience physical and psychological exhaustion, as well as severe anxiety and depression symptoms. This study aimed to explore the relationships between sleep duration, sleep quality, and depression symptoms among nurses during the outbreak of the Omicron variant. A cross-sectional study was conducted between August 2022 and September 2022. Participants (N = 2140) were evaluated for depression symptoms via the Hospital Anxiety and Depression Scale (HADS), and sleep was evaluated via the Pittsburgh Sleep Quality Index (PSQI), and “short sleep duration” was defined as ≤ 5 h per day. Demographic information was also collected. Binary and multivariate logistic regression was performed to assess the relationships between sleep duration, sleep quality, and depression symptoms. In total, 2140 nurses were included in this study; 1481 (69. 2%) had poor sleep quality, while 866 (40. 4%) had depression symptom scores > 7 according to the HADS criteria. Both duration and quality of sleep were significantly correlated with depression symptoms among nurses (P 

Open Access PDF

Concepts Keywords
August Depression
Demographic Nurses
Exhaustion Omicron
Nurses Sleep quality
Pittsburgh Sleep quantity

Semantics

Type Source Name
disease IDO quality
disease MESH depression
disease MESH anxiety
disease MESH sleep quality
disease IDO symptom
pathway REACTOME Reproduction
disease MESH COVID 19 pandemic
drug DRUGBANK Coenzyme M
disease IDO virulence
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Trestolone
disease IDO nucleic acid
drug DRUGBANK Etoperidone
disease MESH infection
disease MESH emotional exhaustion
drug DRUGBANK Isoxaflutole
disease MESH mental disorders
disease IDO production
drug DRUGBANK Hydrocortisone
drug DRUGBANK Melatonin
disease MESH emotional stress
drug DRUGBANK Ademetionine
disease IDO replication
disease MESH marital status
disease MESH educational attainment
disease IDO host
disease MESH privacy
disease MESH sleep latency
drug DRUGBANK L-Valine
drug DRUGBANK Fenamole
drug DRUGBANK Proline
disease MESH major depressive disorder
disease MESH inflammation
disease MESH insufficient sleep
disease MESH obesity
disease IDO susceptibility
disease MESH sleep disorders
disease MESH work related stress
disease MESH causality
disease IDO history
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH emergency
drug DRUGBANK Copper
pathway KEGG Circadian rhythm
drug DRUGBANK Carboxyamidotriazole
disease MESH primary insomnia

Original Article

(Visited 1 times, 1 visits today)